PMID: 7529298Jan 1, 1995Paper

Experimental induction of myelin changes by anti-MAG antibodies and terminal complement complex

Journal of Neuropathology and Experimental Neurology
S MonacoF Tedesco

Abstract

We investigated the role of anti-myelin-associated glycoprotein (MAG) IgM and complement (C) in the pathogenesis of myelin alterations occurring in patients with anti-MAG-associated polyneuropathy. For this purpose, we separately studied the effects of anti-MAG antibodies and terminal C complex (TCC) after injection into the rabbit sciatic nerve. The two different local treatments produced identical ultrastructural abnormalities such as intramyelinic edema, myelin vesiculation and, in particular, separation of the major dense lines with the formation of widely spaced myelin, a peculiar feature encountered in human peripheral nerve disorders with circulating anti-myelin monoclonal IgM. In nerves treated with anti-MAG IgM ultrastructural myelin alterations were concurrent with activation of the rabbit's own C to the formation of TCC. Contrary to the immunological and ultrastructural findings obtained in C-sufficient animals, in C6-deficient rabbits injected with anti-MAG IgM no myelin alterations nor C completion were observed. This study identifies anti-MAG IgM as the mediator and the C as the effector of myelin changes observed in the present model and, for extension, in human neuropathies associated with anti-MAG IgM.

Citations

Jan 1, 1996·Springer Seminars in Immunopathology·H P HartungG Giegerich
Feb 26, 1998·Immunopharmacology·B P MorganS J Piddlesden
Mar 13, 2014·ILAR Journal·Betty Soliven
Jul 16, 2014·Experimental Neurology·Bradley T LangYingjie Shen
Dec 1, 1995·Journal of Neuroimmunology·E NardelliN Rizzuto
Apr 27, 2013·La Presse médicale·Ricard Rojas-GarcíaIsabel Illa
Apr 14, 2009·Clinical Lymphoma & Myeloma·Eduardo Nobile-Orazio
May 11, 2012·Journal of the Peripheral Nervous System : JPNS·Betty Soliven
Oct 8, 2014·Muscle & Nerve·Divisha RahejaZachary Simmons
Dec 17, 2008·Journal of Child Neurology·Gehan Ahmed MostafaMohamed Farouk El-Sayed
Jul 9, 1999·Muscle & Nerve·R H Quarles, M D Weiss
Apr 1, 2000·Journal of Neuropathology and Experimental Neurology·B BonettiG Moretto
Jan 26, 2005·Annals of Neurology·Raffaella LombardiAndreas J Steck
Nov 10, 2021·Expert Review of Clinical Immunology·Norman Latov

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.